Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Planet Fitness rises after update on store reopenings, lifts fitness peers » 14:09
06/02/20
06/02
14:09
06/02/20
14:09
PLNT

Planet Fitness

$72.91 /

+5.3 (+7.84%)

, NLS

Nautilus

$7.34 /

+0.055 (+0.75%)

, PTON

Peloton

$49.22 /

+3.37 (+7.35%)

Shares of Planet Fitness…

Open Full Text

ShowHide Related Items >><<
PTON Peloton
$49.22 /

+3.37 (+7.35%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

NLS Nautilus
$7.34 /

+0.055 (+0.75%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

13:08 Today Roth Capital
Planet Fitness price target raised to $70 from $58 at Roth Capital
06/01/20 Jefferies
Planet Fitness traffic trends improving in reopened states, says Jefferies
05/12/20 Roth Capital
Roth Capital downgrades Planet Fitness to Neutral on resumption of coverage
05/12/20 Roth Capital
Planet Fitness assumed Neutral from Buy at Roth Capital
NLS Nautilus
$7.34 /

+0.055 (+0.75%)

08:40 Today SunTrust
Nautilus price target raised to $10 from $8 at SunTrust
05/06/20 Lake Street
Nautilus price target raised to $9 from $7 at Lake Street
04/23/20
Nautilus upgraded to Buy at SunTrust on expected home fitness surge
PTON Peloton
$49.22 /

+3.37 (+7.35%)

05/19/20 SunTrust
Peloton price target raised to $60 from $52 at SunTrust
05/13/20 Rosenblatt
Peloton on track to meet, potentially beat subscriber guidance, says Rosenblatt
05/13/20 JMP Securities
Peloton price target raised to $59 from $53 at JMP Securities
PTON Peloton
$49.22 /

+3.37 (+7.35%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

NLS Nautilus
$7.34 /

+0.055 (+0.75%)

PTON Peloton
$49.22 /

+3.37 (+7.35%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

PTON Peloton
$49.22 /

+3.37 (+7.35%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

NLS Nautilus
$7.34 /

+0.055 (+0.75%)

PTON Peloton
$49.22 /

+3.37 (+7.35%)

PLNT Planet Fitness
$72.91 /

+5.3 (+7.84%)

Recommendations
Planet Fitness price target raised to $70 from $58 at Roth Capital » 13:08
06/02/20
06/02
13:08
06/02/20
13:08
PLNT

Planet Fitness

$72.50 /

+4.89 (+7.23%)

, NLS

Nautilus

$7.22 /

-0.065 (-0.89%)

, PTON

Peloton

$48.54 /

+2.69 (+5.87%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$48.54 /

+2.69 (+5.87%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

NLS Nautilus
$7.22 /

-0.065 (-0.89%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

06/01/20 Jefferies
Planet Fitness traffic trends improving in reopened states, says Jefferies
05/12/20 Roth Capital
Roth Capital downgrades Planet Fitness to Neutral on resumption of coverage
05/12/20 Roth Capital
Planet Fitness assumed Neutral from Buy at Roth Capital
05/06/20 Wedbush
Planet Fitness price target lowered to $55 from $65 at Wedbush
NLS Nautilus
$7.22 /

-0.065 (-0.89%)

08:40 Today SunTrust
Nautilus price target raised to $10 from $8 at SunTrust
05/06/20 Lake Street
Nautilus price target raised to $9 from $7 at Lake Street
04/23/20
Nautilus upgraded to Buy at SunTrust on expected home fitness surge
04/23/20 SunTrust
Nautilus upgraded to Buy from Hold at SunTrust
PTON Peloton
$48.54 /

+2.69 (+5.87%)

05/19/20 SunTrust
Peloton price target raised to $60 from $52 at SunTrust
05/13/20 Rosenblatt
Peloton on track to meet, potentially beat subscriber guidance, says Rosenblatt
05/13/20 JMP Securities
Peloton price target raised to $59 from $53 at JMP Securities
05/13/20 Stifel
Stifel boosts Peloton target to $55 after connected fitness subs top 1M
PTON Peloton
$48.54 /

+2.69 (+5.87%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

NLS Nautilus
$7.22 /

-0.065 (-0.89%)

PTON Peloton
$48.54 /

+2.69 (+5.87%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

PTON Peloton
$48.54 /

+2.69 (+5.87%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

NLS Nautilus
$7.22 /

-0.065 (-0.89%)

PTON Peloton
$48.54 /

+2.69 (+5.87%)

PLNT Planet Fitness
$72.50 /

+4.89 (+7.23%)

Recommendations
RH price target raised to $265 from $150 at Stifel » 10:54
06/02/20
06/02
10:54
06/02/20
10:54
RH

RH

$235.26 /

+22.72 (+10.69%)

Stifel analyst John Baugh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RH RH
$235.26 /

+22.72 (+10.69%)

RH RH
$235.26 /

+22.72 (+10.69%)

10:07 Today
Fly Intel: Top five analyst upgrades
09:08 Today JPMorgan
JPMorgan ups RH target to $270 from $135 after 'bullish' CEO letter
06:07 Today Gordon Haskett
RH upgraded to Hold from Reduce at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
RH RH
$235.26 /

+22.72 (+10.69%)

RH RH
$235.26 /

+22.72 (+10.69%)

RH RH
$235.26 /

+22.72 (+10.69%)

RH RH
$235.26 /

+22.72 (+10.69%)

Hot Stocks
Planet Fitness up 5% after update on stores reopenings » 10:14
06/02/20
06/02
10:14
06/02/20
10:14
PLNT

Planet Fitness

$70.10 /

+2.49 (+3.68%)

Shares of Planet Fitness…

Shares of Planet Fitness (PLNT) are up in early trading after the company announced earlier in a regulatory filing that as of June 1 the company had reopened approximately 800 stores across 30 states and one province in Canada. The company anticipates that an additional 200 stores may be able to open by mid-June. "At the locations that have reopened, the company has experienced the following results to date: overall average membership levels have remained relatively consistent compared to the day the store reopened, while both joins and cancels have increased compared to the same time period last year; store usage at reopened stores that have been open at least two weeks has increased between the date of reopening and May 31, 2020, with usage indexing at approximately 60% compared to the same time period last year; and Black Card membership percentage for new joins has been approximately 60%, which is consistent with historical levels," Planet Fitness said. In early trading, shares of Planet Fitness are up $3.38, or 5%, to $70.97.

ShowHide Related Items >><<
PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

06/01/20 Jefferies
Planet Fitness traffic trends improving in reopened states, says Jefferies
05/12/20 Roth Capital
Roth Capital downgrades Planet Fitness to Neutral on resumption of coverage
05/12/20 Roth Capital
Planet Fitness assumed Neutral from Buy at Roth Capital
05/06/20 Wedbush
Planet Fitness price target lowered to $55 from $65 at Wedbush
PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

PLNT Planet Fitness
$70.10 /

+2.49 (+3.68%)

Upgrade
Fly Intel: Top five analyst upgrades » 10:07
06/02/20
06/02
10:07
06/02/20
10:07
DGX

Quest Diagnostics

$121.69 /

+3.37 (+2.85%)

, LOW

Lowe's

$130.55 /

+1.19 (+0.92%)

, RH

RH

$230.51 /

+17.97 (+8.45%)

, EV

Eaton Vance

$38.29 /

+1.03 (+2.76%)

, GWW

Grainger

$312.41 /

+7.09 (+2.32%)

, ABBV

AbbVie

$90.58 /

-0.13 (-0.14%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Quest Diagnostics (DGX) resumed to Buy from Hold at Deutsche Bank with analyst Pito Chickering assuming coverage of the stock and saying routine testing is rebounding faster than expected and the COVID-19 testing addressable market is greater than appreciated. 2. Lowe's (LOW) was upgraded to Buy from Hold at Gordon Haskett while RH (RH) was upgraded to Hold from Reduce. 3. Eaton Vance (EV) upgraded to Buy from Neutral at BofA with analyst Michael Carrier citing the company's attractive outlook for margins and cash flow driven by "Parametric, Calvert, and EV Fixed Income" in spite of the floating rate headwinds. 4. Grainger (GWW) upgraded to Buy from Neutral at Longbow with analyst Chris Dankert saying his survey work suggests demand has bottomed during April and May as end customer locations are opening up. 5. AbbVie (ABBV) upgraded to Buy from Hold at Argus with analyst David Toung saying after its completed merger with Allergan, the company's new portfolio includes a "growing oncology franchise anchored by Imbruvica and Venclexta and two growth drivers in the immunology space - Skyrizi and Rinvoq." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RH RH
$230.51 /

+17.97 (+8.45%)

LOW Lowe's
$130.55 /

+1.19 (+0.92%)

GWW Grainger
$312.41 /

+7.09 (+2.32%)

EV Eaton Vance
$38.29 /

+1.03 (+2.76%)

DGX Quest Diagnostics
$121.69 /

+3.37 (+2.85%)

ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

DGX Quest Diagnostics
$121.69 /

+3.37 (+2.85%)

07:20 Today Deutsche Bank
Quest Diagnostics resumed to Buy from Hold at Deutsche Bank
05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
04/28/20
Fly Intel: Top five analyst upgrades
04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
LOW Lowe's
$130.55 /

+1.19 (+0.92%)

06:35 Today Gordon Haskett
Gordon Haskett upgrades Lowe's to Buy, sees continued home investment
06:07 Today Gordon Haskett
Lowe's upgraded to Buy from Hold at Gordon Haskett
05/22/20 Longbow
Lowe's price target raised to $150 from $130 at Longbow
05/21/20
Fly Intel: Top five analyst upgrades
RH RH
$230.51 /

+17.97 (+8.45%)

09:08 Today JPMorgan
JPMorgan ups RH target to $270 from $135 after 'bullish' CEO letter
06:07 Today Gordon Haskett
RH upgraded to Hold from Reduce at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
EV Eaton Vance
$38.29 /

+1.03 (+2.76%)

06:08 Today BofA
Eaton Vance upgraded to Buy from Neutral at BofA
06:02 Today BofA
Eaton Vance upgraded to Buy from Neutral at BofA
01/09/20 BofA
Eaton Vance upgraded on improving flow, fee rate outlook at BofA
01/09/20 BofA
Eaton Vance upgraded to Neutral from Underperform at BofA
GWW Grainger
$312.41 /

+7.09 (+2.32%)

08:10 Today Longbow
Grainger upgraded to Buy on bottoming of demand at Longbow
05:12 Today Longbow
Grainger upgraded to Buy from Neutral at Longbow
04/07/20 Gordon Haskett
Grainger downgraded to Underperform from Hold at Gordon Haskett
04/07/20 Gordon Haskett
Grainger downgraded to Underperform from Hold at Gordon Haskett
ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

08:36 Today JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
07:59 Today Argus
AbbVie upgraded to Buy from Hold at Argus
07:23 Today Argus
AbbVie upgraded to Buy from Hold at Argus
05/22/20 Piper Sandler
Growth of Biohaven's Nurtec continues to beat AbbVie's Ubrelvy, says Piper
RH RH
$230.51 /

+17.97 (+8.45%)

LOW Lowe's
$130.55 /

+1.19 (+0.92%)

GWW Grainger
$312.41 /

+7.09 (+2.32%)

EV Eaton Vance
$38.29 /

+1.03 (+2.76%)

DGX Quest Diagnostics
$121.69 /

+3.37 (+2.85%)

ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

RH RH
$230.51 /

+17.97 (+8.45%)

GWW Grainger
$312.41 /

+7.09 (+2.32%)

ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

RH RH
$230.51 /

+17.97 (+8.45%)

LOW Lowe's
$130.55 /

+1.19 (+0.92%)

DGX Quest Diagnostics
$121.69 /

+3.37 (+2.85%)

ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

RH RH
$230.51 /

+17.97 (+8.45%)

LOW Lowe's
$130.55 /

+1.19 (+0.92%)

DGX Quest Diagnostics
$121.69 /

+3.37 (+2.85%)

ABBV AbbVie
$90.58 /

-0.13 (-0.14%)

Hot Stocks
RH rises 9.4% » 10:00
06/02/20
06/02
10:00
06/02/20
10:00
RH

RH

$232.01 /

+19.47 (+9.16%)

RH is up 9.4%, or $20.03…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RH RH
$232.01 /

+19.47 (+9.16%)

RH RH
$232.01 /

+19.47 (+9.16%)

09:08 Today JPMorgan
JPMorgan ups RH target to $270 from $135 after 'bullish' CEO letter
06:07 Today Gordon Haskett
RH upgraded to Hold from Reduce at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
RH RH
$232.01 /

+19.47 (+9.16%)

RH RH
$232.01 /

+19.47 (+9.16%)

RH RH
$232.01 /

+19.47 (+9.16%)

RH RH
$232.01 /

+19.47 (+9.16%)

Hot Stocks
RH rises 11.4% » 09:47
06/02/20
06/02
09:47
06/02/20
09:47
RH

RH

$236.84 /

+24.3 (+11.43%)

RH is up 11.4%, or $24.31…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RH RH
$236.84 /

+24.3 (+11.43%)

RH RH
$236.84 /

+24.3 (+11.43%)

09:08 Today JPMorgan
JPMorgan ups RH target to $270 from $135 after 'bullish' CEO letter
06:07 Today Gordon Haskett
RH upgraded to Hold from Reduce at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
RH RH
$236.84 /

+24.3 (+11.43%)

RH RH
$236.84 /

+24.3 (+11.43%)

RH RH
$236.84 /

+24.3 (+11.43%)

RH RH
$236.84 /

+24.3 (+11.43%)

Recommendations
JPMorgan ups RH target to $270 from $135 after 'bullish' CEO letter » 09:08
06/02/20
06/02
09:08
06/02/20
09:08
RH

RH

$212.54 /

-4.73 (-2.18%)

JPMorgan analyst Tami…

JPMorgan analyst Tami Zakaria raised the firm's price target on RH to $270 from $135 and keeps an Overweight rating on the shares after CEO Gary Friedman wrote a letter to shareholders. The stock in premarket trading is up 9%, or $19.88, to $232.45. The letter had an "overall bullish tone" and called out a bigger total addressable market of $7 trillion to $10 trillion globally with new business ideas in the works, Zakaria tells investors in a research note. The near term highlight for the analyst was the following statement by Friedman: "We continue to expect operating margins to expand in 2020 despite the current setbacks from COVID-19, and now see a clear path to 20% operating margin over the next few years." This "breaks the structural bear's argument," says the analyst.

ShowHide Related Items >><<
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

06:07 Today Gordon Haskett
RH upgraded to Hold from Reduce at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
04/14/20 Barclays
RH price target raised to $154 from $120 at Barclays
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

Upgrade
RH upgraded to Hold from Reduce at Gordon Haskett » 06:07
06/02/20
06/02
06:07
06/02/20
06:07
RH

RH

$212.54 /

-4.73 (-2.18%)

Gordon Haskett analyst…

Gordon Haskett analyst Chuck Grom upgraded RH to Hold from Reduce with a $220 price target.

ShowHide Related Items >><<
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
04/14/20 Barclays
RH price target raised to $154 from $120 at Barclays
04/01/20 Loop Capital
RH price target lowered to $110 from $210 at Loop Capital
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

Yesterday
Hot Stocks
RH sees 'clear path to 20% operating margins over next few years' » 17:12
06/01/20
06/01
17:12
06/01/20
17:12
RH

RH

$212.54 /

-4.73 (-2.18%)

RH released a copy of…

RH released a copy of Chairman & CEO Gary Friedman's Annual Letter to Shareholders.The letter said in part: "Fiscal 2019 was an outstanding year for Team RH. We achieved record results across every key metric of our business while continuing to elevate the brand and create strategic separation in our industry. Revenues increased 5.4% over last year to $2.647 billion, adjusted operating margins reached an industry best 14.3%, and adjusted diluted earnings per share increased 49% to $11.66. We also generated $330M of free cash flow in 2019, and achieved industry leading ROIC of 35.3%... Our strategy to open new design galleries in every major market will unlock the value of our vast assortment, generating revenues of $5 to $6B North America, with the long term potential to become a $20B dollar global brand. ..Our vision is to move the brand beyond curating and selling product to conceptualizing and selling spaces by building an ecosystem of products, places, services and spaces that elevate and establish the RH brand as a global thought leader, taste, and placemaker...We believe the ecosystem can be expanded globally, multiplying the market opportunity to approximately $7 to $10T, quite possibly one of the largest and most lucrative addressed by any brand in the world today. A one percent share of the global market represents a $70 to $100B opportunity...The emergence of RH as a luxury brand generating luxury margins is becoming evident as our adjusted operating margin has expanded over 700 basis points in the past two years from 7.0% in 2017 to 14.3% in 2019. We continue to expect operating margins to expand in 2020 despite the current setbacks from COVID-19, and now see a clear path to 20% operating margin over the next few years," said RH management in a letter to shareholders.

ShowHide Related Items >><<
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
04/14/20 Barclays
RH price target raised to $154 from $120 at Barclays
04/01/20 Loop Capital
RH price target lowered to $110 from $210 at Loop Capital
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.